MyEczemaTeam

Rinvoq (upadacitinib) is a medication used to treat people 12 years and older with refractory, moderate to severe atopic dermatitis (a common subtype of eczema) that isn’t well controlled with other systemic drugs, including biologics, or when those treatments aren’t recommended. It works by blocking Janus kinase enzymes Show Full Answer

Rinvoq (upadacitinib) is a medication used to treat people 12 years and older with refractory, moderate to severe atopic dermatitis (a common subtype of eczema) that isn’t well controlled with other systemic drugs, including biologics, or when those treatments aren’t recommended. It works by blocking Janus kinase enzymes, which lead to inflammation in atopic dermatitis.

How to Take Rinvoq:
- Taken once a day in the form of an extended-release tablet.

Common Side Effects:
- Upper respiratory infections
- Flu
- Shingles
- Acne
- Cold sores
- Headache
- Cough
- Allergic reactions
- Nausea
- Fever
- Weight gain

Rare but Serious Side Effects:
- Life-threatening infections (including tuberculosis)
- Lymphomas
- Blood clots
- Gastrointestinal tears
- Fetal harm during pregnancy
- Retinal detachment

For more details, you can visit the [Rinvoq page on MyEczemaTeam](https://www.MyEczemaTeam.com/treatments/rinvoq) or the [Rinvoq Prescribing Information](https://www.rxabbvie.com/pdf/rinvoq_pi.pdf).

If you have personal experiences with Rinvoq, sharing them with others can be very helpful!

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Rinvoq (Upadacitinib) for Eczema | MyEczemaTeam

Opzelura (Ruxolitinib) for Eczema | MyEczemaTeam